Blocking a Cancer-Related Pathway Helps Reduce Spine Deformities Due to Genetic Disorder, Finds New Study

Researchers identify bone-forming cells as the driver of scoliosis caused by a genetic disorder, which can be prevented ...

Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

The securities described above were offered by Erasca pursuant to a shelf registration statement on Form S-3, including a base prospectus, that was previously filed with the Securities and Exchange ...
The Brighterside of News on MSN

Scientists find a natural 'off switch' for inflammation in humans

Inflammation can feel like a small storm inside your body. It brings heat, swelling, and pain as the immune system rushes to ...
BioWorld

Erasca raises $225M to sharpen RAS oncology focus

Erasca Inc. priced an upsized public offering to raise $225 million to fund development of its therapies for patients with RAS/MAPK pathway-driven cancers.
Frontiers

Natural Products Targeting the MAPK Signaling Pathway: Potential Options for Ulcerative Colitis Treatment

The final, formatted version of the article will be published soon. As a chronic, recurrent inflammatory bowel disease, ulcerative colitis (UC) poses significant clinical challenges due to its ...

Erasca, Inc.: Erasca Announces Pricing of Upsized Public Offering of Common Stock

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for ...

Erasca Announces Pricing of Upsized Public Offering of Common Stock

(Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today ...

Erasca, Inc.: Erasca Announces Proposed Public Offering of $150 Million of Common Stock

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for ...
EurekAlert!

Hollings researchers reveal why some pancreatic tumors behave differently

A new study led by MUSC Hollings Cancer Center researchers Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., sheds light on why ...

Scientists Discover the Body’s Natural “Off Switch” for Inflammation

A human study reveals how naturally occurring fat-derived molecules help switch off inflammation. Researchers at (UCL) have identified an important biological process that helps the body bring ...